MSK (exam 7 pharm) Flashcards
Osteoporosis risk factors
menopause, over 60yo
family hx
systemic prolonged glucocorticoids and anticonvulsants
high alcohol and caffeine consumption
low vietamin D and Calcium intake
tobacco use
physical inactivity
testosterone deficiency
Two types of drugs for osteoporosis
- decrease bone reabsorption
- promote bone formation
drugs that decrease bone resorption
calcium and vitamin D
Estrogen replacement therapy
estrogen receptor modulators
biphosphonates
calcitonin
drugs that promote bone formation
teriparatide
Saldium supplement recommendation / day
ADR
Route for severe hypocalcemia
1000mg/day or 1200-1500 post menopause
ADR: hypercalcemia
Parenteral for severe
Vitamin D drug examples
calciferol
ergocalciferol
ADR of vitamin D
hypercalcemia
most common drug class for osteoporosis
bisphosphonates
bisphosphonates MOA
inhibit bone resorption by decreasing osteoclast activity
Bisphosphonates examples
ibandronate
alendronate
Bisphosphonates route
PO, on an empty stomach
or IV
Ibandronate PO 1/month
Ibandronate IV 1/ 3 months
Bisphosphonates ADR
esophagitis/esophageal ulcer
Atypical femoral fractures
osteonecrosis of jaw
ocular problems
Bisphosphonates PO instruction
in the morning at least 30 mins before intake
with full glass of water
remain upright for 30 mins
Estrogen replacement
HRT (hormone replacement therapy)
selective estrogen recepter modifier (SERM) drug
raloxifene
Raloxifene MOA
binds to estrogen receptors, blocks receptors on uterus and breast
raloxifene ADR
thrombolytic events
DVT and PE
Calcitonin is secreted from the
thyroid gland
Calcitonin MOA
lowers serum calcium by moving calcium to the bone
Calcitonin route
SC or nasal spray
teriparatide is a form of what?
PTH
Teriparatide does
creates bone formation (increase bone deposition by osteoblasts)
teriparatide ADR:
arthralgia/back pain/leg cramps
orthostatic hypotension 4 hours after injection
osteosarcoma
daily
Denosumab is what type of drug?
monoclonal antibody
Denosumab action
decrease formation and function of osteoclasts
denocumab admin route
SQ 1x per month
denosumab ADR
back pain
hypocalcemia
infection
derm reactions
osteonecrosis of jaw
Drug classes to treat RA
NSAIDS
Glucocorticoids
disease modifying anti rheumatic drugs (DMARD)
Nsaids in RA management
Do not prevent joint damage
do not slow disease progress
releives symptoms